Sanofi India Ltd

Sanofi India Ltd

₹ 5,550 -4.72%
01 Aug - close price
About

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.[1]

Key Points

Parent Company[1]
Sanofi Global and its 100% subsidiary - Hoechst GmbH, are the shareholders of Sanofi India and together hold 60.40%. Company's follows parent company's financial year hence, Financial year is same as Calender Year.

  • Market Cap 12,756 Cr.
  • Current Price 5,550
  • High / Low 7,600 / 4,146
  • Stock P/E 35.8
  • Book Value 340
  • Dividend Yield 2.11 %
  • ROCE 49.2 %
  • ROE 47.2 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 40.6%
  • Company has been maintaining a healthy dividend payout of 113%

Cons

  • Stock is trading at 16.3 times its book value
  • The company has delivered a poor sales growth of -8.10% over past five years.
  • Debtor days have increased from 27.6 to 41.7 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
699 692 672 736 515 491 469 511 464 524 515 536 406
538 510 505 507 393 377 370 374 348 404 397 364 311
Operating Profit 161 182 167 230 122 114 100 137 116 120 118 172 95
OPM % 23% 26% 25% 31% 24% 23% 21% 27% 25% 23% 23% 32% 23%
16 11 34 44 57 82 77 41 21 2 14 3 9
Interest 0 0 0 0 1 0 0 0 0 0 0 0 0
Depreciation 11 10 10 10 9 9 9 9 9 9 10 10 9
Profit before tax 166 182 190 264 169 186 167 169 127 113 122 165 94
Tax % 27% 28% 31% 28% 27% 18% 18% 19% 19% 27% 25% 28% 26%
120 131 131 190 123 152 138 137 103 82 91 120 70
EPS in Rs 52.35 56.91 56.91 82.78 53.43 66.17 59.87 59.39 44.96 35.74 39.70 51.96 30.22
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 TTM
1,809 1,977 2,193 2,367 2,460 2,771 3,071 2,902 2,957 2,770 1,996 2,013 1,981
1,411 1,639 1,817 1,832 1,921 2,146 2,403 2,186 2,194 2,066 1,508 1,522 1,476
Operating Profit 398 339 376 535 538 625 667 716 762 704 488 491 505
OPM % 22% 17% 17% 23% 22% 23% 22% 25% 26% 25% 24% 24% 25%
83 131 218 66 79 88 33 45 564 204 318 79 28
Interest 0 0 0 2 1 1 0 2 2 2 2 2 2
Depreciation 92 97 113 119 102 103 100 82 67 42 36 37 37
Profit before tax 388 373 481 480 515 610 600 677 1,258 864 767 531 494
Tax % 32% 29% 33% 37% 37% 38% 31% 29% 25% 28% 21% 22%
265 264 322 304 326 381 414 478 944 621 603 414 362
EPS in Rs 115.30 114.61 139.78 132.26 141.74 165.48 180.09 207.65 410.61 269.83 262.26 179.78 157.62
Dividend Payout % 39% 39% 46% 51% 50% 51% 194% 176% 119% 211% 64% 65%
Compounded Sales Growth
10 Years: 0%
5 Years: -8%
3 Years: -12%
TTM: 2%
Compounded Profit Growth
10 Years: 8%
5 Years: 0%
3 Years: -9%
TTM: 1%
Stock Price CAGR
10 Years: 8%
5 Years: 3%
3 Years: 11%
1 Year: -16%
Return on Equity
10 Years: 24%
5 Years: 32%
3 Years: 41%
Last Year: 47%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Jun 2025
Equity Capital 23 23 23 23 23 23 23 23 23 23 23 23 23
Reserves 1,324 1,463 1,604 1,860 2,003 2,196 2,419 2,096 2,203 1,253 992 838 759
0 0 0 0 0 0 0 23 25 24 19 19 21
532 742 778 658 751 765 802 777 811 772 681 732 436
Total Liabilities 1,878 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,715 1,612 1,239
699 648 877 817 769 733 499 464 334 306 315 312 309
CWIP 136 210 22 34 30 21 17 10 13 24 16 18 16
Investments 0 0 0 0 0 0 0 0 0 0 2 0 0
1,043 1,369 1,505 1,690 1,978 2,230 2,728 2,444 2,714 1,743 1,382 1,281 914
Total Assets 1,878 2,228 2,405 2,541 2,778 2,984 3,244 2,918 3,061 2,072 1,715 1,612 1,239

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024
273 265 213 322 435 374 412 611 559 399 231 462
-335 61 36 -155 -79 -73 66 276 631 651 36 -178
-105 -122 -147 -180 -188 -197 -183 -810 -849 -1,583 -878 -392
Net Cash Flow -168 205 102 -13 168 104 295 78 341 -533 -612 -109

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2013 Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024
Debtor Days 24 21 24 22 29 21 27 19 18 17 24 42
Inventory Days 151 179 173 169 151 154 127 107 110 125 254 186
Days Payable 83 122 81 79 119 110 100 93 105 109 112 151
Cash Conversion Cycle 92 78 115 112 61 65 54 33 22 33 167 77
Working Capital Days 43 26 9 79 17 18 35 -8 -20 -19 35 20
ROCE % 29% 22% 26% 27% 26% 29% 28% 32% 35% 41% 44% 49%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40%
8.26% 6.99% 6.71% 6.72% 6.80% 6.31% 6.11% 5.81% 5.78% 5.64% 5.58% 5.61%
18.28% 19.22% 19.46% 19.65% 21.68% 22.51% 22.88% 22.60% 22.62% 22.94% 23.02% 23.06%
13.08% 13.41% 13.43% 13.22% 11.10% 10.78% 10.61% 11.21% 11.20% 11.04% 11.01% 10.94%
No. of Shareholders 73,73474,59376,69471,51368,59862,87061,84967,66266,21166,40168,19666,790

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls